LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorZhejiang Cancer Hospital

About this trial

Researchers will use LCMS Metabolic Analysis to Explore the Effect of American Ginseng on Urine and Plasma in Healthy Individuals

Participants will:

* Take 3 grams of American Ginseng powder every day for 14 days * Collect the fasting urine samples at the following times at the hospital: On the first day, on the 7th day after taking the medicine, and on the 14th day after taking the medicine. * Collect the fasting Serum samples at the following times at the hospital: On the first day and on the 14th day after taking the medicine. * Have their any adverse effects monitored and evaluated throughout the study.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 to 45 years old;

The subjects were fully informed about the research process and signed the informed consent form (the subjects had no abnormalities in routine physical examinations, no previous medical history, and no history of drug allergies); ③ During the trial, they were required to have a light diet and were prohibited from consuming alcoholic and caffeinated beverages;

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • American Gginseng

    Other intervention

    All the subjects took 3 grams of ginseng half an hour after breakfast every day for 14 consecutive days.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: American Ginseng groupOther 1 intervention

Trial outcomes

Primary outcomes

1

Urine metabolomics

By using LCMS Metabolic Analysis to Explore the Effect of American Ginseng on Urine in Healthy Individuals

Time frame
From enrollment to the end of treatment at 2 weeks

Secondary outcomes

1

Plasma metabolomics

By using LCMS Metabolic Analysis to Explore the Effect of American Ginseng on plasma in Healthy Individuals.

Time frame
From enrollment to the end of treatment at 2 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.